目的 系統(tǒng)評價阿苯達(dá)唑治療肝細(xì)粒棘球蚴?。℉CE)的療效。
方法 通過計算機檢索和手工檢索,全面收集阿苯達(dá)唑治療HCE的隨機和半隨機對照試驗,按Cochrane協(xié)作網(wǎng)推薦的方法進(jìn)行分析。
結(jié)果 僅2個試驗符合納入標(biāo)準(zhǔn),其方法學(xué)質(zhì)量評價均為“B”級。1個研究比較了阿苯達(dá)唑與甲苯達(dá)唑治療HCE的療效,結(jié)果顯示其包囊數(shù)和病例數(shù)的有效率,兩組差異均無統(tǒng)計學(xué)意義[RR 1.19,95%CI(0.97,1.46);RR 1.35,95%CI(0.91,2.00)]。另一個研究比較了阿苯達(dá)唑聯(lián)合手術(shù)與單純手術(shù)治療HCE的療效,結(jié)果顯示,阿苯達(dá)唑治療1月再手術(shù)與直接手術(shù)療效比較差異無統(tǒng)計學(xué)意義[RR 1.63,95%CI(0.90,2.93)],阿苯達(dá)唑治療3月再手術(shù)與直接手術(shù)療效比較差異有統(tǒng)計學(xué)意義[RR 1.89,95%CI(1.09,3.29)]。
結(jié)論 ① 阿苯達(dá)唑與甲苯達(dá)唑治療HCE的療效相似;② 阿苯達(dá)唑聯(lián)合手術(shù)治療與單純手術(shù)治療相比,阿苯達(dá)唑治療療程應(yīng)足夠長(3個月)才會顯示出聯(lián)合治療的優(yōu)越性。但由于本系統(tǒng)評價納入試驗數(shù)和病例數(shù)較少,測量指標(biāo)不全面,因此會影響到上述結(jié)論的強度。要確定阿苯達(dá)唑治療HCE的效果,尚需開展更多高質(zhì)量試驗。
引用本文: 王濤,劉雅莉,楊克虎,金鳳玲,景濤,曹農(nóng),田金徽,馬彬,楊林. 阿苯達(dá)唑治療肝細(xì)粒棘球蚴病的系統(tǒng)評價. 中國循證醫(yī)學(xué)雜志, 2007, 07(11): 789-793. doi: 復(fù)制
版權(quán)信息: ?四川大學(xué)華西醫(yī)院華西期刊社《中國循證醫(yī)學(xué)雜志》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編
1. | Wen H, Yao BL, Zou PF, et al. Determination of albendazole and RTS metabolites in serum bile and cystic fluid by HPLC. Endemic Disease Bulletin, 1989, 4(4): 52-54. |
2. | Chai JJ, Meng HB, Jiao W, et al. Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases, 2001, 19(3): 129-134.. |
3. | CSBTS, MOH. Diagnostic criteria and treatment principle of echinococcosis. The National Standards of the People’s Republic of China, 1997, GB7013. |
4. | Tan JZ, Wang LW. Observision of clinical curative effect with abendazole longer therapy in hydatid disease, edemic aviso. Endemic Disease Bulletin, 1995, 10(1): 67-68. |
5. | Zhang HL, Zhu QY, Jiing Q, et al. A comparative trial of clinical efficacy of emulsion albendazole in treatment of hepatic cystic echinococcosis. Chinese Journal of Parasitic Disease Control, 2002, 15(4): 228-229. |
6. | Qian XM. Progress in surgical treatment of hydatid disease in China clinical analysis of 2005 surgical case. Chinese Medical Journal, 1995, 108(4): 2952. |
7. | Wen H, Zou PF, Yang WG, et al. Abendazole chemotherapy for human cystic and alveolar echinococcosis in Northwestern China. Trans Rsoc Trop MedHyg, 1994, 340-343. |
8. | 溫浩, 姚秉禮, 鄒培范, 等. 高效液相色譜法測定人體血液膽汁和包蟲囊液的丙硫咪唑及代謝產(chǎn)物的含量. 地方病通報, 1989, 4(4): 52-54. |
9. | 柴君杰, 孟賀巴特, 焦偉, 等. 阿苯達(dá)唑乳劑治療肝囊型包蟲病212例臨床療效觀察. 中國寄生蟲學(xué)與寄生蟲病雜志, 2001, 19(3): 129-134.. |
10. | 國家技術(shù)監(jiān)督局, 中華人民共和國衛(wèi)生部. 包蟲病診斷標(biāo)準(zhǔn)及處理原則. 中華人民共和國國家標(biāo)準(zhǔn), 1997, GB7013. |
11. | 譚家忠, 王龍文. 阿苯達(dá)唑長期治療肝包蟲的臨床觀察. 地方病通報. 1995, 10(1): 67-68. |
12. | 張賀玲, 朱其銀, 荊強, 等. 兩種劑型阿苯達(dá)唑治療肝囊型包蟲病的療效對照觀察, 中國寄生蟲病防治雜志, 2002, 15(4): 228-229. |
13. | Mohamed AE, Yasawy MI, Al-Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology, 1998, 45(23): 1690-1694. |
14. | Gupta SK, Schantz PM, Donaldson JS. Recurrent hydatid disease after therapy with albendazole. Pediatr Infect Dis J, 1993, 12(6): 535-536. |
15. | Morris DL, Taylor. Sensitivity to albendazole sulphoxide of echinococcus granulosus scoleces in man. Lancet, 1986, 2(8514): 1035. |
16. | Davis A, Pawlowski ZS, Dixon H. Multicetre clinical trials of benzimidazole carbamates in human echinococcosis. Bulletin of the World Health Organization, 1986, 64(3): 383-388. |
17. | Davis A, Dixon H, Pawlowski ZS. Multicetre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bulletin of the World Health Organization, 1989, 67(5): 503-508. |
18. | Wilcox MH, Morris DL, Bailey JW. Serology in patients treated with albendazole for hydatid disease. J R Soc Med, 1988, 81(12): 714-717. |
19. | Mohammed SK, Yousuf D, Ghulam NY. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology, 1993, 104: 1452-1459. |
20. | Cristiana F, Bruno DV, Antonella T. Long-Term Evaluation of Patients with Hydatidosis Treated with Benzimidazole Carbamates. Clinical Infectious Diseases, 1999, 29: 304-309. |
21. | Evangelos C, Tsimoyiannis PS, Kyriaki J. Moutesidou.Periopertive Benzimidazole Therapy in Human Hydaid Liver Disease. Int Surg, 1995, 80: 131-133. |
22. | Byt Todorov K, Vutova G, Mechkov P. Georgiev. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology, 1992, 86(1): 59-66. |
23. | Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet, 1993, 342(8882): 1269-1272. |
- 1. Wen H, Yao BL, Zou PF, et al. Determination of albendazole and RTS metabolites in serum bile and cystic fluid by HPLC. Endemic Disease Bulletin, 1989, 4(4): 52-54.
- 2. Chai JJ, Meng HB, Jiao W, et al. Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases, 2001, 19(3): 129-134..
- 3. CSBTS, MOH. Diagnostic criteria and treatment principle of echinococcosis. The National Standards of the People’s Republic of China, 1997, GB7013.
- 4. Tan JZ, Wang LW. Observision of clinical curative effect with abendazole longer therapy in hydatid disease, edemic aviso. Endemic Disease Bulletin, 1995, 10(1): 67-68.
- 5. Zhang HL, Zhu QY, Jiing Q, et al. A comparative trial of clinical efficacy of emulsion albendazole in treatment of hepatic cystic echinococcosis. Chinese Journal of Parasitic Disease Control, 2002, 15(4): 228-229.
- 6. Qian XM. Progress in surgical treatment of hydatid disease in China clinical analysis of 2005 surgical case. Chinese Medical Journal, 1995, 108(4): 2952.
- 7. Wen H, Zou PF, Yang WG, et al. Abendazole chemotherapy for human cystic and alveolar echinococcosis in Northwestern China. Trans Rsoc Trop MedHyg, 1994, 340-343.
- 8. 溫浩, 姚秉禮, 鄒培范, 等. 高效液相色譜法測定人體血液膽汁和包蟲囊液的丙硫咪唑及代謝產(chǎn)物的含量. 地方病通報, 1989, 4(4): 52-54.
- 9. 柴君杰, 孟賀巴特, 焦偉, 等. 阿苯達(dá)唑乳劑治療肝囊型包蟲病212例臨床療效觀察. 中國寄生蟲學(xué)與寄生蟲病雜志, 2001, 19(3): 129-134..
- 10. 國家技術(shù)監(jiān)督局, 中華人民共和國衛(wèi)生部. 包蟲病診斷標(biāo)準(zhǔn)及處理原則. 中華人民共和國國家標(biāo)準(zhǔn), 1997, GB7013.
- 11. 譚家忠, 王龍文. 阿苯達(dá)唑長期治療肝包蟲的臨床觀察. 地方病通報. 1995, 10(1): 67-68.
- 12. 張賀玲, 朱其銀, 荊強, 等. 兩種劑型阿苯達(dá)唑治療肝囊型包蟲病的療效對照觀察, 中國寄生蟲病防治雜志, 2002, 15(4): 228-229.
- 13. Mohamed AE, Yasawy MI, Al-Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology, 1998, 45(23): 1690-1694.
- 14. Gupta SK, Schantz PM, Donaldson JS. Recurrent hydatid disease after therapy with albendazole. Pediatr Infect Dis J, 1993, 12(6): 535-536.
- 15. Morris DL, Taylor. Sensitivity to albendazole sulphoxide of echinococcus granulosus scoleces in man. Lancet, 1986, 2(8514): 1035.
- 16. Davis A, Pawlowski ZS, Dixon H. Multicetre clinical trials of benzimidazole carbamates in human echinococcosis. Bulletin of the World Health Organization, 1986, 64(3): 383-388.
- 17. Davis A, Dixon H, Pawlowski ZS. Multicetre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bulletin of the World Health Organization, 1989, 67(5): 503-508.
- 18. Wilcox MH, Morris DL, Bailey JW. Serology in patients treated with albendazole for hydatid disease. J R Soc Med, 1988, 81(12): 714-717.
- 19. Mohammed SK, Yousuf D, Ghulam NY. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology, 1993, 104: 1452-1459.
- 20. Cristiana F, Bruno DV, Antonella T. Long-Term Evaluation of Patients with Hydatidosis Treated with Benzimidazole Carbamates. Clinical Infectious Diseases, 1999, 29: 304-309.
- 21. Evangelos C, Tsimoyiannis PS, Kyriaki J. Moutesidou.Periopertive Benzimidazole Therapy in Human Hydaid Liver Disease. Int Surg, 1995, 80: 131-133.
- 22. Byt Todorov K, Vutova G, Mechkov P. Georgiev. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology, 1992, 86(1): 59-66.
- 23. Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet, 1993, 342(8882): 1269-1272.